Skip to main content
Signal8

Lundberg Sven Ante

SEC insider (Form 3/4/5 filer). CIK 0001682126. Director at Yarrow Bioscience, Inc. (YARW) and 3 other issuers. 47 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in WALTHAM, MA.

Companies Lundberg Sven Ante has filed insider reports for

  • Yarrow Bioscience, Inc. (YARW): Director
  • Q32 Bio Inc. (QTTB): Director
  • Merus N.V. (MRUS): Director, Officer, President, CEO & PEO
  • Vor Biopharma Inc. (VOR): Director
Lundberg Sven Ante profile photo

Lundberg Sven Ante

CIK: 0001682126

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (6.4%)

Derivative conversions

Awards (A)13 (27.7%)

Compensation grants

Other (G, F, J, C, D, …)31 (66.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Yarrow Bioscience, Inc. logo
YARW

Yarrow Bioscience, Inc.

Director
Q32 Bio Inc. logo
QTTB

Q32 Bio Inc.

Director
Merus N.V. logo
MRUS

Merus N.V.

DirectorOfficer
Vor Biopharma Inc. logo
VOR

Vor Biopharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (47 total)

  • Q32 Bio Inc. logo
    QTTB

    Q32 Bio Inc.

    Jun 12, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    10.8K shares-
  • Q32 Bio Inc. logo
    QTTB

    Q32 Bio Inc.

    Jun 12, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    9.8K shares-
  • Q32 Bio Inc. logo
    QTTB

    Q32 Bio Inc.

    Jan 15, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    20.4K shares at avg. $2.75-
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Disposition

    Share Option (right to buy)

    Direct
    300K shares-
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Disposition

    Share Option (right to buy)

    Direct
    312.6K shares-
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Disposition

    Share Option (right to buy)

    Direct
    351.6K shares-
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Tender Offer
    Indirect
    9.2K shares at avg. $97.00$892K
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Tender Offer
    Indirect
    16.4K shares at avg. $97.00$1.6M
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Tender Offer
    Indirect
    9.2K shares at avg. $97.00$892K
  • Merus N.V. logo
    MRUS

    Merus N.V.

    Dec 12, 2025
    Tender Offer
    Indirect
    30.3K shares at avg. $97.00$2.9M

1-10 of 47